Excellerant (EXCL) 10-K 20 Nov 20 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Sep. 30, 2020	Nov. 19, 2020	Mar. 31, 2020
Details
Registrant CIK	0001786119
Fiscal Year End	--09-30
Registrant Name	Excellerant, Inc.
SEC Form	10-K
Period End date	Sep. 30, 2020
Tax Identification Number (TIN)	98-1497791
Number of common stock shares outstanding		5,648,000
Public Float			$ 0
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Interactive Data Current	Yes
Voluntary filer	No
Well-known Seasoned Issuer	No
Shell Company	false
Small Business	true
Emerging Growth Company	true
Ex Transition Period	true
Entity File Number	333-234796
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	302 Yayun Ave, Panyu,
Entity Address, City or Town	Guangzhou
Entity Address, Postal Zip Code	510000
Entity Address, Country	CN
Country Region	+1
City Area Code	702
Local Phone Number	776-9823
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Document Annual Report	true
Document Transition Report	false

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Sep. 30, 2020	Sep. 30, 2019
Current Assets
Escrow account	$ 20,745	$ 0
Total Current Assets	20,745	0
Total Assets	20,745	0
Current Liabilities
Accrued expenses	0	4,500
Accounts payable - related party	16,000	4,000
Director loan	10,832	2,223
Total Current Liabilities	26,832	10,723
Stockholders' Equity (Deficit)
Common stock, par value $0.0001; 75,000,000 shares authorized, 5,648,000 and 3,000,000 shares issued and outstanding respectively;	564	300
Additional paid-in capital	26,216	0
Accumulated deficit	(32,867)	(11,023)
Total Stockholders' Equity (Deficit)	(6,087)	(10,723)
Total Liabilities and Stockholders' Equity	$ 20,745	$ 0

BALANCE SHEETS - Parenthetical

BALANCE SHEETS - Parenthetical - $ / shares	Sep. 30, 2020	Sep. 30, 2019
Details
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Shares, Outstanding	5,648,000	3,000,000

STATEMENT OF OPERATION

STATEMENT OF OPERATION - USD ($)	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Details
REVENUES	$ 0	$ 0
Bank Service Charges	285	0
Business License and Permits	836	0
Professional Fees	13,223	7,023
Consulting Expense - Related party	12,000	4,000
Net income (loss) from operation	(26,344)	(11,023)
Income loss before taxes	(26,344)	(11,023)
Provision for taxes	0	0
Net (loss)	$ (26,344)	$ (11,023)
Net loss per common share, basic and diluted	$ (0.01)	$ 0
Weighted average number of common shares outstanding, basic and diluted	4,147,037	3,000,000

STATEMENT OF STOCKHOLDER EQUITY

STATEMENT OF STOCKHOLDER EQUITY - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Equity Balance at Sep. 30, 2018	$ 0	$ 0	$ 0	$ 0
Equity Balance, Shares at Sep. 30, 2018	0
Shares issued for compensation, value	$ 300	0	0	300
Shares issued for compensation, shares	3,000,000
Net Income (loss) for the period	$ 0	0	(11,023)	(11,023)
Equity Balance, Shares at Sep. 30, 2019	3,000,000
Equity Balance at Sep. 30, 2019	$ 300	0	(11,023)	(10,723)
Shares issued for compensation, value	$ 264	26,216	0	26,480
Shares issued for compensation, shares	2,648,000
Net Income (loss) for the period	$ 0	0	(26,344)	(26,344)
Equity Balance, Shares at Sep. 30, 2020	5,648,000
Equity Balance at Sep. 30, 2020	$ 564	$ 26,216	$ (32,867)	$ (6,087)

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (loss) for the period	$ (26,344)	$ (11,023)
Changes in assets and liabilities:
Increase (decrease) in accrued expenses	0	4,000
Increase (decrease) in accounts payable	12,000	4,500
CASH FLOWS USED IN OPERATING ACTIVITIES	(14,344)	(2,523)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Director Loan	8,609	2,223
Proceeds from capital stock	26,480	300
NET CASH PROVIDED BY FINANCING ACTIVITIES	35,089	2,523
Net increase in cash and equivalents	20,745	0
Cash and equivalents at the beginning of period	0	0
Cash and equivalents at end of period	20,745	0
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	0	0
Income taxes paid	$ 0	$ 0

ORGANIZATION AND NATURE OF BUSI

ORGANIZATION AND NATURE OF BUSINESS	12 Months Ended
	Sep. 30, 2020
Notes
ORGANIZATION AND NATURE OF BUSINESS	NOTE 1 - ORGANIZATION AND NATURE OF BUSINESS EXCELLERANT, INC. (“the Company,”, “we,” “us” or “our”) was incorporated in the State of Nevada on May 30, 2019. Our company is planning to offer a broad range of health advisory and tour services: consulting services in the field of traditional and alternative medicine and medical technologies in China; helping our customers to choose a clinic for treatment; consulting customers and helping them to arrange the itinerary, by building a route, which includes clinics, hospitals and other medical institution; providing guide services to our potential clients. We also provide them with information concerning transportation, the cost of it, how it operates and what are the best medical institutions. We are going to provide our services both to legal entities and individuals. The company’s address is 302 Yayun Ave, Panyu, Guangzhou, Guangdong 510000, China.

GOING CONCERN DISCLOSURE

GOING CONCERN DISCLOSURE	12 Months Ended
	Sep. 30, 2020
Notes
GOING CONCERN DISCLOSURE	NOTE 2 - GOING CONCERN The Company’s financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the financial statements, the Company had an accumulated deficit of $(32,867) at September 30, 2020, a net loss of $(26,344) September 30, 2020. The Company has a cash balance of $20,745 at September 30, 2020. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company is attempting to commence operations and generate sufficient revenue; however, the Company’s cash position may not be sufficient to support the Company’s daily operations. Management intends to raise additional funds by way of a private or public offering. While the Company believes in the viability of its strategy to commence operations and generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of a public or private offering. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Coronavirus (“COVID-19”) pandemic could adversely impact our operations, demand for our products and services and our operating results. The impact of the coronavirus ("COVID-19") outbreak on the financial condition of the Company will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions and the impact of COVID-19 on the overall economy, all of which are highly uncertain and cannot be predicted. If the overall economy is impacted for an extended period, the Company’s future operating results may be materially adversely affected.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Sep. 30, 2020
Notes
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America. The Company’s year-end is September 30, 2020. Development Stage Company The Company is a development stage company as defined in ASC 915 “Development Stage Entities.”. The Company is devoting substantially all of its efforts on establishing the business and its planned principal operations have not commenced. All losses accumulated since inception have been considered as part of the Company's development stage activities. The Company has elected to adopt application of Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. Upon adoption, the Company no longer presents or discloses inception-to-date information and other remaining disclosure requirements of Topic 915. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company entered a Trust Agreement with the director and set up Related Party Trust Account for holding funds in relation to issuing shares for stock consideration of $20,745. The Company has $20,745 cash as of September 30, 2020. Fair Value of Financial Instruments AS topic 820 "Fair Value Measurements and Disclosures" establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. These tiers include: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The carrying value of cash and the Company’s loan from shareholder approximates its fair value due to their short-term maturity. Income Taxes Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. Basic Income (Loss) Per Share The Company computes income (loss) per share in accordance with FASB ASC 260 “Earnings per Share”. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of September 30, 2020, there were no potentially dilutive debt or equity instruments issued or outstanding. Stock-Based Compensation Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying financial statements.

LOAN FROM DIRECTOR DISCLOSURE

LOAN FROM DIRECTOR DISCLOSURE	12 Months Ended
	Sep. 30, 2020
Notes
LOAN FROM DIRECTOR DISCLOSURE	NOTE 4 - LOAN FROM DIRECTOR The Company has received capital from the director of the Company to pay for the Company expenses that are unsecured, non-interest bearing and due on demand. The outstanding amounts were $10,832 as of September 30, 2020.

ESCROW ACCOUNT DISCLOSURE

ESCROW ACCOUNT DISCLOSURE	12 Months Ended
	Sep. 30, 2020
Notes
ESCROW ACCOUNT DISCLOSURE	NOTE 5- ESCROW ACCOUNT The Company is utilizing a trust account in RMB currency; it fluctuates immaterial amounts each day and is converted to USD for reporting currency on financial statements. The foreign currency exchange difference is immaterial to these financial statements.

COMMON STOCK DISCLOSURE

COMMON STOCK DISCLOSURE	12 Months Ended
	Sep. 30, 2020
Notes
COMMON STOCK DISCLOSURE	NOTE 6 - COMMON STOCK The Company has 75,000,000, $0.0001 par value shares of voting common stock authorized. In March 2020 the Company issued 420,000 common shares to 5 shareholders as per subscription agreement at $0.01 per share for a total price of $4,200. In April and May 2020 the Company issued 2,228,000 of common shares as per subscription agreements at $0.01 per share for a total price of $22,280. As of September 30, 2020 the Company had 5,648,000 shares issued and outstanding. Common Stock All shares of common stock have voting rights and are identical. All holders of shares of common stock shall at every meeting of the stockholders be entitled to one vote for each share of the capital stock held by such stockholder.

COMMITMENTS AND CONTINGENCIES D

COMMITMENTS AND CONTINGENCIES DISCLOSURE	12 Months Ended
	Sep. 30, 2020
Notes
COMMITMENTS AND CONTINGENCIES DISCLOSURE	NOTE 7- COMMITMENTS AND CONTINGENCIES Our sole officer and director, Lasha Morbedadze, has agreed to provide his own premise under office needs. He will not take any fee for these premises, it is for free use. Lasha Morbedadze has executed consulting agreement receiving $1,000 per month for providing consulting services to the Company. The contract was executed on June 01, 2019 and continues for 24 months.

INCOME TAXES DISCLOSURE

INCOME TAXES DISCLOSURE	12 Months Ended
	Sep. 30, 2020
Notes
INCOME TAXES DISCLOSURE	NOTE 8 - INCOME TAXES On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (“Tax Reform Act”). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system and imposing a transition tax on deemed repatriated earnings of foreign subsidiaries. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2019. As a result of the reduction in the U.S. corporate income tax rate from 34% to 21% under the Tax Reform Act, the Company revalued its ending net deferred tax assets. The reconciliation of income tax benefit (expenses) at the U.S. statutory rate of 34% for the period ended as follows: September 30, 2020 2019 Tax benefit (expenses) at U.S. statutory rate $ (5,532) $ (2,314) Change in valuation allowance 5,532 2,314 Tax benefit (expenses), net $ -- $ -- The tax effects of temporary differences that give rise to significant portions of the net deferred tax assets are as follows: September 30, 2020 2019 Net operating loss $ 6,902 $ 2,314 Valuation allowance 6,902 2,314 Deferred tax assets, net $ -- $ -- The Company has accumulated approximately $32,867of net operating losses (“NOL”) carried forward to offset future taxable income up to 20 years, if any, in future years which begin to expire in year 2038. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against all of the deferred tax asset relating to NOLs for every period because it is more likely than not that all of the deferred tax asset will not be realized.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Sep. 30, 2020
Notes
SUBSEQUENT EVENTS	NOTE 9 - SUBSEQUENT EVENTS In accordance with ASC 855-10 the Company has analyzed its operations subsequent to September 30, 2020 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Basis of Presentation (Policies)	12 Months Ended
	Sep. 30, 2020
Policies
Basis of Presentation	Basis of presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America. The Company’s year-end is September 30, 2020.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Use of Estimates Policy (Policies)	12 Months Ended
	Sep. 30, 2020
Policies
Use of Estimates Policy	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Cash and Cash Equivalents Policy (Policies)	12 Months Ended
	Sep. 30, 2020
Policies
Cash and Cash Equivalents Policy	Cash and Cash Equivalents The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company entered a Trust Agreement with the director and set up Related Party Trust Account for holding funds in relation to issuing shares for stock consideration of $20,745. The Company has $20,745 cash as of September 30, 2020.

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Fair value of financial instruments, Policy (Policies)	12 Months Ended
	Sep. 30, 2020
Policies
Fair value of financial instruments, Policy	Fair Value of Financial Instruments AS topic 820 "Fair Value Measurements and Disclosures" establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. These tiers include: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The carrying value of cash and the Company’s loan from shareholder approximates its fair value due to their short-term maturity.

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Income Taxes, Policy (Policies)	12 Months Ended
	Sep. 30, 2020
Policies
Income Taxes, Policy	Income Taxes Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Basic Income (Loss) Per Share, Policy (Policies)	12 Months Ended
	Sep. 30, 2020
Policies
Basic Income (Loss) Per Share, Policy	Basic Income (Loss) Per Share The Company computes income (loss) per share in accordance with FASB ASC 260 “Earnings per Share”. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of September 30, 2020, there were no potentially dilutive debt or equity instruments issued or outstanding.

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Share-based Compensation Policy (Policies)	12 Months Ended
	Sep. 30, 2020
Policies
Share-based Compensation Policy	Stock-Based Compensation Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Recent Accounting Pronouncements (Policies)	12 Months Ended
	Sep. 30, 2020
Policies
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying financial statements.

INCOME TAXES DISCLOSURE_ Schedu

INCOME TAXES DISCLOSURE: Schedule of Components of Income Tax Expense (Benefit) (Tables)	12 Months Ended
	Sep. 30, 2020
Tables/Schedules
Schedule of Components of Income Tax Expense (Benefit)	September 30, 2020 2019 Tax benefit (expenses) at U.S. statutory rate $ (5,532) $ (2,314) Change in valuation allowance 5,532 2,314 Tax benefit (expenses), net $ -- $ --

INCOME TAXES DISCLOSURE_ Sche_2

INCOME TAXES DISCLOSURE: Schedule of Deferred Tax Assets (Tables)	12 Months Ended
	Sep. 30, 2020
Tables/Schedules
Schedule of Deferred Tax Assets	September 30, 2020 2019 Net operating loss $ 6,902 $ 2,314 Valuation allowance 6,902 2,314 Deferred tax assets, net $ -- $ --

GOING CONCERN DISCLOSURE (Detai

GOING CONCERN DISCLOSURE (Details) - USD ($)	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Details
Accumulated deficit	$ (32,867)	$ (11,023)
Net (loss)	(26,344)	$ (11,023)
Cash balance	$ 20,745

SUMMARY OF SIGNIFICANT ACCOU_10

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Cash and Cash Equivalents Policy (Details)	Sep. 30, 2020USD ($)
Details
Cash balance	$ 20,745

LOAN FROM DIRECTOR DISCLOSURE (

LOAN FROM DIRECTOR DISCLOSURE (Details) - USD ($)	Sep. 30, 2020	Sep. 30, 2019
Details
Outstanding loan due to a director	$ 10,832	$ 2,223

COMMON STOCK DISCLOSURE (Detail

COMMON STOCK DISCLOSURE (Details) - USD ($)	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Common shares authorized	75,000,000	75,000,000
Par value of common shares	$ 0.0001	$ 0.0001
Common shares outstanding	5,648,000	3,000,000
Sale of stock, March 2020
Shares issued for cash, shares	420,000
Shares issued for cash, value	$ 4,200
Sale of stock, April and May 2020
Shares issued for cash, shares	2,228,000
Shares issued for cash, value	$ 22,280

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES DISCLOSURE (Details)	12 Months Ended
	Sep. 30, 2020USD ($)
Details
Monthly compensation, officer	$ 1,000

INCOME TAXES DISCLOSURE_ Sche_3

INCOME TAXES DISCLOSURE: Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Details
Tax benefit (expenses) at U.S. statutory rate	$ (5,532)	$ (2,314)
Change in valuation allowance	5,532	2,314
Tax benefit (expenses), net	$ 0	$ 0

INCOME TAXES DISCLOSURE_ Sche_4

INCOME TAXES DISCLOSURE: Schedule of Deferred Tax Assets (Details) - USD ($)	Sep. 30, 2020	Sep. 30, 2019
Details
Net operating losses carried forward	$ 6,902	$ 2,314
(Less) Valuation allowance	6,902	2,314
Deferred tax assets, net	$ 0	$ 0

INCOME TAXES DISCLOSURE (Detail

INCOME TAXES DISCLOSURE (Details)	Sep. 30, 2020USD ($)
Details
Operating losses carried forward	$ 32,867